Cardiac allograft vasculopathy: a donor or recipient induced pathology?
about
Cardiac allograft vasculopathy in Dutch heart transplant recipients.Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study.Controlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia-reperfusion injury.Transplantation of Hearts Donated after Circulatory Death.
P2860
Cardiac allograft vasculopathy: a donor or recipient induced pathology?
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cardiac allograft vasculopathy: a donor or recipient induced pathology?
@ast
Cardiac allograft vasculopathy: a donor or recipient induced pathology?
@en
type
label
Cardiac allograft vasculopathy: a donor or recipient induced pathology?
@ast
Cardiac allograft vasculopathy: a donor or recipient induced pathology?
@en
prefLabel
Cardiac allograft vasculopathy: a donor or recipient induced pathology?
@ast
Cardiac allograft vasculopathy: a donor or recipient induced pathology?
@en
P2093
P2860
P921
P1476
Cardiac allograft vasculopathy: a donor or recipient induced pathology?
@en
P2093
Manon M H Huibers
Patricia van den Hoogen
Roel A de Weger
P2860
P2888
P304
P356
10.1007/S12265-015-9612-X
P407
P577
2015-02-05T00:00:00Z